Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.25B	12.40%	2.80%	7.74%	5.90%	3.95	2.91	31.70%	2.70%	6.83%
EMBC	EMBECTA CORP	$814.69M	-7.00%	4.40%	19.34%	7.60%	-2.52	2.48	63.50%	4.90%	15.42%
AMRX	AMNEAL PHARMACEUTICALS INC	$2.95B	-3.00%	0.10%	12.55%	8.20%	-31.53	1.43	37.70%	0.10%	10.19%
INDV	INDIVIOR PLC	$2.87B	-56.00%	8.90%	64.65%	78.00%	-6.65	0.90	84.00%	10.90%	21.81%
KMDA	KAMADA LTD	$424.39M	7.40%	5.20%	6.05%	15.50%	0.42	4.00	43.60%	11.20%	11.51%
TBRG	TRUBRIDGE INC	$300.38M	-5.80%	-2.50%	6.18%	9.80%	1.25	1.80	52.80%	-2.80%	6.04%
AUPH	AURINIA PHARMACEUTICALS INC	$1.58B	16.70%	11.50%	15.80%	14.50%	0.50	5.23	89.50%	23.30%	25.77%
EHAB	ENHABIT INC	$383.33M	-24.00%	-10.70%	-8.67%	-14.00%	1.22	1.49	49.00%	-13.40%	-9.19%
GRFS	GRIFOLS SA	$7.32B	2.70%	0.70%	5.73%	5.80%	2.18	2.66	38.70%	2.20%	15.29%
RIGL	RIGEL PHARMACEUTICALS INC	$656.15M	438.90%	57.00%	88.99%	124.70%	1.52	2.02	91.50%	36.50%	39.89%
HALO	HALOZYME THERAPEUTICS INC	$7.62B	136.60%	26.40%	36.99%	27.90%	5.17	8.36	84.20%	47.30%	60.25%
LIVN	LIVANOVA PLC	$2.90B	-17.70%	-8.40%	-7.27%	-13.90%	1.23	1.29	69.10%	-16.10%	-9.33%
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	$1.49B	-18.90%	1.10%	15.00%	13.30%	-148.62	1.09	33.30%	0.90%	9.35%
MD	PEDIATRIX MEDICAL GROUP INC	$1.35B	14.10%	5.30%	10.21%	18.50%	1.52	1.80	24.40%	5.70%	9.26%
ANIP	ANI PHARMACEUTICALS INC	$1.92B	-5.40%	-1.90%	-0.83%	-1.00%	2.03	2.66	59.30%	-3.40%	-1.35%
INFU	INFUSYSTEM HOLDINGS INC	$190.37M	9.10%	4.90%	12.11%	9.60%	0.85	2.19	54.50%	3.60%	7.36%
STE	STERIS PLC	$24.33B	9.70%	6.30%	9.72%	17.30%	0.49	2.22	44.10%	11.60%	16.54%
NVST	ENVISTA HOLDINGS CORP	$3.58B	1.80%	1.00%	3.18%	7.10%	0.81	2.44	54.70%	2.10%	6.07%
MDXG	MIMEDX GROUP INC	$1.08B	16.20%	12.00%	17.68%	40.40%	0.34	4.39	81.50%	8.80%	11.70%
TBPH	THERAVANCE BIOPHARMA INC	$625.49M	6.90%	3.50%	11.49%	15.90%	0.90	6.71	100.00%	16.90%	55.25%
ARDT	ARDENT HEALTH PARTNERS INC	$1.81B	22.30%	5.20%	9.43%	8.10%	2.70	2.13	18.30%	4.10%	6.31%
BMRN	BIOMARIN PHARMACEUTICAL INC	$11.19B	11.50%	9.20%	12.57%	15.10%	0.24	5.56	79.60%	21.50%	27.78%
TFX	TELEFLEX INC	$5.43B	4.50%	2.60%	4.92%	10.00%	0.74	2.41	55.60%	6.30%	10.78%
SIGA	SIGA TECHNOLOGIES INC	$628.70M	40.50%	35.60%	50.40%	194.00%	0.12	10.09	76.90%	45.70%	59.65%
NBIX	NEUROCRINE BIOSCIENCES INC	$13.05B	13.20%	9.40%	15.76%	15.90%	0.44	3.20	98.50%	13.90%	21.00%
SNN	SMITH & NEPHEW PLC	$16.14B	7.70%	3.90%	7.03%	8.30%	0.93	3.00	69.60%	7.10%	11.07%
ONC	BEONE MEDICINES LTD	$33.87B	-5.10%	-3.00%	-2.23%	-4.10%	0.67	1.95	85.50%	-3.90%	-1.99%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.22B	19.20%	2.90%	12.45%	18.20%	5.96	1.08	57.70%	6.60%	21.45%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$2.49B	1.00%	0.80%	2.62%	4.30%	0.34	3.57	85.90%	0.90%	2.69%
THC	TENET HEALTHCARE CORP	$15.18B	37.30%	5.10%	11.81%	13.00%	5.44	1.71	100.00%	7.20%	13.95%
BVS	BIOVENTUS INC	$622.57M	-0.10%	0.00%	6.80%	8.10%	3.14	1.48	67.60%	0.00%	6.29%
FONR	FONAR CORP	$100.37M	4.70%	3.70%	5.86%	6.70%	0.32	10.05	41.20%	7.70%	11.42%
INCY	INCYTE CORP	$16.76B	24.10%	15.80%	27.84%	62.90%	0.40	2.85	92.90%	19.00%	27.59%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.79B	N/A	-7.40%	22.20%	6.00%	-2.08	2.25	97.00%	-6.40%	11.15%
SHC	SOTERA HEALTH CO	$4.46B	5.80%	0.80%	8.77%	7.10%	6.48	2.46	55.20%	2.20%	22.75%
SPOK	SPOK HOLDINGS INC	$386.29M	11.10%	8.10%	13.89%	43.90%	0.38	1.24	79.60%	12.10%	16.11%
SOLV	SOLVENTUM CORP	$12.87B	12.30%	2.60%	6.25%	7.10%	3.45	1.19	54.60%	4.60%	8.99%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.18B	N/A	-9.90%	-2.16%	-1.70%	-18.34	1.95	82.20%	-13.00%	-2.10%
NVS	NOVARTIS AG	$234.63B	32.60%	13.30%	23.01%	40.10%	1.49	0.82	76.20%	24.70%	30.30%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$7.63B	-2.00%	-0.90%	1.48%	1.70%	1.24	1.36	32.50%	-1.70%	2.38%
GRDN	GUARDIAN PHARMACY SERVICES INC	$1.49B	-61.50%	-26.90%	-36.56%	-60.30%	1.04	1.18	19.60%	-6.90%	-5.85%
ALNY	ALNYLAM PHARMACEUTICALS INC	$56.69B	-274.20%	-7.40%	-6.96%	-4.50%	17.22	2.80	83.60%	-13.00%	-9.23%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.34B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
IRWD	IRONWOOD PHARMACEUTICALS INC	$177.05M	N/A	-2.20%	70.34%	10.10%	-2.11	0.83	100.00%	-2.60%	25.18%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$43.84M	-12.80%	-4.40%	-5.98%	-9.20%	1.45	1.25	84.30%	-8.00%	-6.46%
ELMD	ELECTROMED INC	$165.46M	16.50%	13.90%	21.86%	35.00%	0.19	5.19	77.60%	11.70%	15.64%
NAGE	NIAGEN BIOSCIENCE INC	$807.10M	35.50%	23.80%	26.49%	199.80%	0.43	3.88	63.60%	15.20%	15.76%
VRTX	VERTEX PHARMACEUTICALS INC	$101.51B	22.10%	15.90%	22.07%	31.10%	0.40	2.52	86.10%	31.90%	38.45%
MIRM	MIRUM PHARMACEUTICALS INC	$3.27B	-24.80%	-8.50%	-7.40%	-10.50%	1.85	3.13	79.00%	-13.60%	-10.02%
INVA	INNOVIVA INC	$1.30B	5.70%	3.00%	7.86%	9.00%	0.87	2.64	86.60%	10.40%	23.09%
CAH	CARDINAL HEALTH INC	$35.37B	-52.00%	3.20%	16.22%	36.00%	-20.05	0.94	3.70%	0.70%	1.04%
AMED	AMEDISYS INC	$3.32B	7.30%	3.90%	10.46%	33.90%	0.76	1.36	43.20%	3.60%	7.52%
BWAY	BRAINSWAY LTD	$238.93M	9.00%	5.70%	9.19%	51.50%	0.64	3.51	74.50%	11.60%	17.17%
LLY	ELI LILLY & CO	$625.13B	88.40%	16.00%	27.24%	22.10%	4.52	1.28	82.60%	25.90%	31.66%
VTRS	VIATRIS INC	$12.14B	-19.90%	-8.50%	-10.40%	-14.20%	1.47	1.37	36.60%	-24.60%	-23.04%
CRMD	CORMEDIX INC	$819.32M	22.60%	17.00%	14.95%	53.00%	0.30	4.21	95.20%	20.80%	20.85%
VMD	VIEMED HEALTHCARE INC	$284.30M	10.50%	7.90%	14.12%	21.00%	0.31	1.48	58.30%	5.80%	8.63%
IRMD	IRADIMED CORP	$903.12M	23.30%	20.60%	26.67%	70.60%	0.13	8.78	77.00%	26.60%	33.54%
UHS	UNIVERSAL HEALTH SERVICES INC	$11.50B	18.00%	8.30%	13.82%	13.10%	1.18	1.32	41.80%	7.40%	10.78%
BIIB	BIOGEN INC	$19.82B	9.00%	5.40%	7.15%	15.70%	0.61	2.50	75.40%	15.30%	17.98%
AMRN	AMARIN CORP PLC	$310.24M	-21.20%	-15.00%	-20.11%	-26.80%	0.44	3.26	37.50%	-47.20%	-44.38%
MMSI	MERIT MEDICAL SYSTEMS INC	$5.10B	8.50%	4.80%	7.62%	10.10%	0.74	4.09	47.90%	8.30%	12.56%
AXGN	AXOGEN INC	$679.15M	-4.40%	-2.30%	1.81%	1.50%	0.83	4.14	74.30%	-2.30%	1.60%
OMCL	OMNICELL INC	$1.44B	1.80%	1.10%	1.00%	2.70%	0.70	1.42	43.70%	2.00%	1.34%
EW	EDWARDS LIFESCIENCES CORP	$45.61B	41.30%	31.60%	36.31%	71.50%	0.27	4.68	78.90%	73.00%	77.18%
AZN	ASTRAZENECA PLC	$241.61B	19.80%	7.80%	14.82%	26.20%	1.51	0.86	81.40%	14.70%	20.68%
PBYI	PUMA BIOTECHNOLOGY INC	$263.08M	49.30%	18.20%	39.47%	61.20%	1.02	1.53	72.40%	16.40%	18.58%
OPRX	OPTIMIZERX CORP	$320.52M	-13.10%	-9.10%	-6.83%	-19.20%	0.44	2.82	64.10%	-16.30%	-10.81%
IDXX	IDEXX LABORATORIES INC	$53.12B	64.40%	29.90%	59.89%	50.70%	1.28	1.11	61.50%	24.40%	31.25%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$288.68M	7.30%	5.30%	10.14%	17.90%	0.40	3.79	74.70%	5.10%	7.90%
EHC	ENCOMPASS HEALTH CORP	$12.00B	30.70%	9.80%	15.98%	14.00%	1.62	1.06	26.50%	11.50%	16.69%
MASI	MASIMO CORP	$8.47B	-40.80%	-17.60%	-24.18%	-21.70%	1.30	2.15	52.80%	-24.80%	-23.69%
PODD	INSULET CORP	$21.73B	18.40%	7.20%	13.03%	11.10%	1.37	2.26	70.70%	10.00%	13.58%
WAY	WAYSTAR HOLDING CORP	$6.16B	2.80%	1.90%	4.65%	14.50%	0.47	3.43	67.30%	8.50%	20.80%
ELAN	ELANCO ANIMAL HEALTH INC	$8.85B	6.70%	3.30%	6.36%	10.60%	1.03	2.60	54.70%	9.70%	17.51%
DH	DEFINITIVE HEALTHCARE CORP	$561.38M	-77.30%	-31.70%	-52.05%	-106.80%	1.18	1.65	76.40%	-124.40%	-131.52%
BTSG	BRIGHTSPRING HEALTH SERVICES INC	$3.97B	3.90%	1.10%	6.23%	6.90%	2.41	1.76	12.90%	0.50%	2.31%
GSK	GSK PLC	$79.49B	24.20%	5.80%	12.18%	16.10%	3.04	0.87	71.40%	10.80%	14.97%
BSX	BOSTON SCIENTIFIC CORP	$151.88B	11.50%	6.30%	9.18%	16.10%	0.84	1.37	68.30%	13.50%	18.05%
DXCM	DEXCOM INC	$31.36B	25.60%	8.50%	19.99%	14.40%	1.85	1.52	58.80%	13.30%	18.67%
GILD	GILEAD SCIENCES INC	$149.07B	32.90%	11.20%	18.42%	23.70%	1.84	1.32	78.50%	21.90%	28.42%
NHC	NATIONAL HEALTHCARE CORP	$1.68B	11.00%	7.20%	11.48%	13.30%	0.54	1.90	100.00%	7.80%	10.87%
ADUS	ADDUS HOMECARE CORP	$2.14B	8.40%	6.20%	9.68%	45.50%	0.38	1.74	32.60%	6.50%	9.56%
PGNY	PROGYNY INC	$1.98B	11.80%	7.80%	17.52%	24.70%	0.56	2.39	22.00%	4.30%	7.12%
RPRX	ROYALTY PHARMA PLC	$21.26B	10.20%	5.70%	7.52%	5.50%	0.93	1.26	100.00%	44.30%	55.83%
AKBA	AKEBIA THERAPEUTICS INC	$866.70M	N/A	-18.90%	-9.98%	-30.20%	11.62	2.23	68.00%	-24.50%	-11.82%
HCA	HCA HEALTHCARE INC	$91.37B	-189.60%	10.00%	23.00%	12.80%	-13.83	0.98	40.90%	8.20%	13.79%
SNWV	SANUWAVE HEALTH INC	$341.20M	N/A	-125.30%	125.29%	108.30%	-2.78	0.40	76.60%	-89.90%	-56.82%
BMY	BRISTOL MYERS SQUIBB CO	$97.40B	29.60%	5.40%	9.80%	10.50%	4.43	1.21	70.30%	10.60%	13.79%
FMS	FRESENIUS MEDICAL CARE AG	$14.58B	4.70%	2.00%	5.33%	5.90%	1.28	1.44	24.70%	3.40%	7.00%
LGND	LIGAND PHARMACEUTICALS INC	$3.06B	-9.20%	-8.10%	-9.15%	-17.30%	0.15	5.45	93.00%	-40.40%	-43.10%
ZYME	ZYMEWORKS INC	$971.39M	-31.60%	-24.00%	-29.74%	-33.70%	0.31	4.71	100.00%	-121.70%	-114.77%
GMAB	GENMAB A	$14.54B	24.70%	19.90%	30.06%	75.00%	0.22	6.22	94.40%	37.60%	52.88%
PCRX	PACIRA BIOSCIENCES INC	$1.13B	-16.50%	-8.20%	-7.18%	-7.60%	1.03	2.38	78.20%	-18.10%	-12.45%
ABBV	ABBVIE INC	$355.91B	142.10%	2.70%	5.67%	8.40%	-750.38	0.74	70.90%	6.50%	9.48%
SYK	STRYKER CORP	$144.88B	14.10%	6.50%	8.58%	12.50%	1.19	1.78	64.10%	12.30%	14.07%
OPCH	OPTION CARE HEALTH INC	$4.63B	15.20%	6.20%	12.95%	17.40%	1.49	1.52	19.70%	3.90%	6.29%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$19.74B	-2.60%	-0.40%	3.19%	4.00%	4.88	1.06	49.60%	-1.00%	5.42%
ZVRA	ZEVRA THERAPEUTICS INC	$529.35M	4.00%	1.30%	13.14%	23.30%	1.19	7.85	72.00%	4.30%	48.18%
HCSG	HEALTHCARE SERVICES GROUP INC	$1.11B	2.20%	1.30%	3.26%	4.00%	0.68	2.49	10.90%	0.60%	1.08%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+2.48%	+3.77%	+5.21%	-64.19%	-116.66x	4.42x	-120.38%	-6.57%	-1.26%	+92.47%	Strong Buy
Diagnostics & Research	57	+2.21%	+7.73%	+11.47%	-10.87%	23.71x	3.85x	-3.69%	+7.41%	+14.41%	+5.93%	Buy
Drug Manufacturers - General	18	+2.48%	-1.19%	-4.06%	-14.33%	33.81x	5.81x	+58.35%	+10.31%	+17.74%	+54.45%	Buy
Drug Manufacturers - Specialty & Generic	77	+1.76%	+7.17%	+1.16%	-66.57%	-13.96x	2.23x	+12.17%	+4.87%	+10.46%	+36.02%	Buy
Healthcare Plans	11	+2.23%	+7.66%	-6.23%	-37.93%	13.04x	1.75x	+15.38%	+4.83%	+11.28%	+25.79%	Buy
Health Information Services	55	+3.20%	+5.99%	+3.90%	-58.26%	80.97x	4.08x	+7.34%	+4.85%	+9.57%	+20.99%	Strong Buy
Medical Care Facilities	48	+1.35%	+6.93%	+1.12%	-33.23%	15.88x	4.69x	-194.39%	+6.84%	+15.18%	+18.01%	Buy
Medical Devices	141	+1.93%	+5.91%	-0.90%	-21.15%	31.33x	3.98x	+13.21%	+8.46%	+9.36%	+28.40%	Strong Buy
Medical Distribution	10	+0.78%	-3.27%	-6.03%	+19.44%	26.31x	283.82x	-5.94%	+3.41%	+19.16%	+17.42%	Buy
Medical Instruments & Supplies	55	+2.36%	+3.54%	+1.28%	-58.50%	33.51x	3.53x	+10.62%	+8.34%	+11.10%	+22.48%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 75.79% over the past year, overperforming other healthcare stocks by 124 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -1.49% from Phibro Animal Health's current stock price of $30.96.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.97% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.92% from Embecta's current stock price of $13.94.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 34, which is 9 points higher than the healthcare sector average of 25. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 20.23% over the past year, overperforming other healthcare stocks by 68 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $11.50, an upside of 22.34% from Amneal Pharmaceuticals's current stock price of $9.40.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.99%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.99%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.02%, which is 12 percentage points higher than the healthcare sector average of 1.99%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 2.2% in the last day, and up 4.67% over the last week. Sonoma Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 72.67% yesterday.

Sonoma Pharmaceuticals shares are trading higher after the company launched a HOCI-based diaper rash product in 3,600 Walmart stores and online.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.98% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -5.97% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -15.96% in the past year. It has overperformed other stocks in the healthcare sector by 32 percentage points.

Are healthcare stocks a good buy now?

50.72% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.11% over the next year.

5.58% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.98% of healthcare stocks are rated B (Buy), 42.35% are rated C (Hold), 26.1% are rated D (Sell), and 14% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 6.69x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Amneal Pharmaceuticals (NASDAQ:AMRX)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Amneal Pharmaceuticals (NASDAQ:AMRX)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.